153 related articles for article (PubMed ID: 32416524)
1. Use of analgesics following rescheduling of codeine in Australia: An interrupted time series analysis in the veteran population.
Kalisch Ellett LM; Kemp-Casey A; Kassie GM; Pratt NL; Roughead EE
Int J Drug Policy; 2020 Jul; 81():102767. PubMed ID: 32416524
[TBL] [Abstract][Full Text] [Related]
2. Changes in sales of analgesics to pharmacies after codeine was rescheduled as a prescription only medicine.
Schaffer AL; Cairns R; Brown JA; Gisev N; Buckley NA; Pearson SA
Med J Aust; 2020 Apr; 212(7):321-327. PubMed ID: 32200566
[TBL] [Abstract][Full Text] [Related]
3. Changes in Australian prescription opioid use following codeine rescheduling: A retrospective study using pharmaceutical benefits data.
Middleton M; Nielsen S
Int J Drug Policy; 2019 Dec; 74():170-173. PubMed ID: 31622949
[TBL] [Abstract][Full Text] [Related]
4. Impact of a policy change restricting access to codeine on prescription opioid-related emergency department presentations: an interrupted time series analysis.
Elphinston RA; Connor JP; de Andrade D; Hipper L; Freeman C; Chan G; Sterling M
Pain; 2021 Apr; 162(4):1095-1103. PubMed ID: 33086287
[TBL] [Abstract][Full Text] [Related]
5. Hospital admissions for paracetamol poisoning declined following codeine re-scheduling in Australia.
Noghrehchi F; Cairns R; Buckley NA
Int J Drug Policy; 2023 Jun; 116():104040. PubMed ID: 37116402
[TBL] [Abstract][Full Text] [Related]
6. Codeine use and harms in Australia: evaluating the effects of re-scheduling.
Cairns R; Schaffer AL; Brown JA; Pearson SA; Buckley NA
Addiction; 2020 Mar; 115(3):451-459. PubMed ID: 31577369
[TBL] [Abstract][Full Text] [Related]
7. Prescription opioid dispensing in Australian children and adolescents: a national population-based study.
Bell J; Paget SP; Nielsen TC; Buckley NA; Collins J; Pearson SA; Nassar N
Lancet Child Adolesc Health; 2019 Dec; 3(12):881-888. PubMed ID: 31604614
[TBL] [Abstract][Full Text] [Related]
8. Dental opioid prescribing rates after the up-scheduling of codeine in Australia.
Teoh L; Hollingworth S; Marino R; McCullough MJ
Sci Rep; 2020 May; 10(1):8463. PubMed ID: 32439950
[TBL] [Abstract][Full Text] [Related]
9. The impact of codeine re-scheduling on misuse: a retrospective review of calls to Australia's largest poisons centre.
Cairns R; Brown JA; Buckley NA
Addiction; 2016 Oct; 111(10):1848-53. PubMed ID: 27177599
[TBL] [Abstract][Full Text] [Related]
10. Prescription opioid analgesics for pain management in Australia: 20 years of dispensing.
Islam MM; McRae IS; Mazumdar S; Taplin S; McKetin R
Intern Med J; 2016 Aug; 46(8):955-63. PubMed ID: 26602489
[TBL] [Abstract][Full Text] [Related]
11. Up-scheduling and codeine supply in Australia: analysing the intervention and outliers.
Yu Y; Wilson M; King CE; Hill R
Addiction; 2021 Dec; 116(12):3463-3472. PubMed ID: 33999465
[TBL] [Abstract][Full Text] [Related]
12. A wastewater-based evaluation of the effectiveness of codeine control measures in Australia.
Tscharke BJ; O'Brien JW; Ahmed F; Nguyen L; Ghetia M; Chan G; Thai P; Gerber C; Bade R; Mueller J; Thomas KV; White J; Hall W
Addiction; 2023 Mar; 118(3):480-488. PubMed ID: 36367203
[TBL] [Abstract][Full Text] [Related]
13. To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?
Gisev N; Pearson SA; Karanges EA; Larance B; Buckley NA; Larney S; Dobbins T; Blanch B; Degenhardt L
Pharmacoepidemiol Drug Saf; 2018 May; 27(5):550-555. PubMed ID: 29047196
[TBL] [Abstract][Full Text] [Related]
14. The impact of proposed regulatory changes and rescheduling on low-dose codeine purchasing in Canada: a time-series analysis.
Boone CG; Antoniou T; Juurlink DN; von den Baumen TR; Kitchen SA; Richards GC; Tadrous M; Gomes T
CMAJ Open; 2021; 9(4):E1181-E1186. PubMed ID: 34906994
[TBL] [Abstract][Full Text] [Related]
15. A prospective cohort study evaluating the impact of upscheduling codeine in Australia among frequent users of codeine.
McCoy J; Nielsen S; Bruno R
Addiction; 2022 Mar; 117(3):677-686. PubMed ID: 34490926
[TBL] [Abstract][Full Text] [Related]
16. Twenty-five years of prescription opioid use in Australia: a whole-of-population analysis using pharmaceutical claims.
Karanges EA; Blanch B; Buckley NA; Pearson SA
Br J Clin Pharmacol; 2016 Jul; 82(1):255-67. PubMed ID: 26991673
[TBL] [Abstract][Full Text] [Related]
17. The Promotion of Policy Changes Restricting Access to Codeine Medicines on Twitter: What do National Pain Organizations Say?
Elphinston RA; Scotti Requena S; Angus D; de Andrade D; Freeman CR; Day MA
J Pain; 2020; 21(7-8):881-891. PubMed ID: 31857206
[TBL] [Abstract][Full Text] [Related]
18. The impact of more restrictive hydrocodone rescheduling on unintentional pediatric opioid exposures.
Mallama C; Karami S; Zhang D; Zhao Y; Yang Y; Woods C; Ding Y; Meyer T; McAninch J
Pharmacoepidemiol Drug Saf; 2024 Jun; 33(6):e5793. PubMed ID: 38783553
[TBL] [Abstract][Full Text] [Related]
19. The views of Australian adults experiencing pain on the upscheduling of codeine-containing analgesics to 'prescription only'.
Mishriky J; Stupans I; Chan V
Int J Clin Pharm; 2021 Apr; 43(2):386-393. PubMed ID: 32301065
[TBL] [Abstract][Full Text] [Related]
20. Trends in analgesic exposures reported to Texas Poison Centers following increased regulation of hydrocodone.
Haynes A; Kleinschmidt K; Forrester MB; Young A
Clin Toxicol (Phila); 2016 Jun; 54(5):434-40. PubMed ID: 26919555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
